About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Journal of Cancer Research and Clinical Oncology
›
Top Articles
Journal of Cancer Research and Clinical Oncology
Oncology
4.9
(top 3%)
Impact Factor
5.2
(top 3%)
extended IF
108
(top 3%)
H-Index
4.3K
authors
9.9K
papers
154.5K
citations
7.3K
citing journals
73.3K
citing authors
Most Cited Articles of Journal of Cancer Research and Clinical Oncology
Title
Year
Citations
Organotrope carcinogene Wirkungen bei 65 verschiedenen N-Nitroso-Verbindungen an BD-Ratten
1967
1.2K
Randomized controlled trial of screening for hepatocellular carcinoma
2004
912
Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR
1992
677
Inhibition of protein phosphatases by microcystins and nodularin associated with hepatotoxicity
1990
495
The Wnt signaling pathway and its role in tumor development
2003
425
Cancer active targeting by nanoparticles: a comprehensive review of literature
2015
400
Hereditary cancer: two hits revisited
1996
377
A decade's studies on metastasis of hepatocellular carcinoma
2004
376
Cyclooxygenase-2: a novel target for cancer chemotherapy?
2001
339
Multicellular spheroids. A review on cellular aggregates in cancer research
1987
338
Giant cell tumor of bone: treatment and outcome of 214 cases
2008
276
Radiation-induced fibrosis: mechanisms and implications for therapy
2015
250
Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer
2010
238
Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study
2008
236
The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma
2017
232
Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma
2013
227
Estimation of liver tumor volume using different formulas - an experimental study in rats
1983
222
A review of clinical and molecular prognostic factors in osteosarcoma
2008
215
Morphological grades of regression in osteosarcoma after polychemotherapy - study COSS 80
1983
214
Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression
2017
207
Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents
1987
200
Ferricenium complexes: a new type of water-soluble antitumor agent
1984
198
The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis
2014
197
MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis
2011
197
Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases
2010
196
previous
2006
2007
2008
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.